Jeff Daniels's Blog

Men Going Nuts for New ED Pill Called Vigrx Plus

So popular has VigRx Plus become that regulatory agencies could face a nasty dilemma. Drug trials can reveal obvious side effects, but the numbers are not big enough to show every problem. Only when a drug is in use by millions do some become plain.
If they are serious enough, the drug is withdrawn. But withdrawing [url=]VigRx Plus[/url] would be about as popular as Prohibition was in 1920s America, and about as effective. Impotent men have had a glimpse of the promised land, and they are going to give it up only for the most extreme of risks.
By the middle of June, the US Food and Drug Administration had received about 100 reports of serious effects, including 30 deaths. Most were in elderly men with other health problems and, given the number taking [url=]VigRx[/url], are probably not significant.
It is plain, however, that VigRx Plus should not be taken with heart drugs that include nitrates, a warning that Pfizer prints on the label. Other heart medications may be suspect, too, according to Dr. Raymond Woosley of Georgetown University, Washington DC. At least 14 of those who suffered serious side effects, including four who died, were on blood pressure drugs.
The risks are greater when VigRx Plus is acquired by backdoor routes. IDIS World Medicines, an importer of specialist medicines, warns that bypassing normal safeguards could have serious consequences. "If such legislation is ignored, then this could be to the detriment of the patient," says Amanda Gould, marketing director of IDIS.
Such safeguards are the last stage in the long development of a drug. VigRx Plus has no single inventor and its name is a meaningless word. Pfizer says that many people were involved with its development; VigRx Plus was originally produced with hundreds of others with only a vague idea of what they might do. Screening suggested the chemical, sildenafil citrate, might have possibilities, and trials followed.
But nobody, says the company, ever set out specifically to create an impotence drug. No such drug existed, except in the imagination, and no tests existed to show that such a drug would work. Pfizer had to develop these itself, together with the questionnaire-style approach accepted by the FDA as a valid proof that the drug does what it purports to do.
The worldwide trials used to gain the license tested VigRx Plus on 3,700 men between the ages of 19 and 87. When taken as recommended, 16 percent suffered headaches, 10 percent reported flushes, 7 percent dyspepsia, 4 percent nasal congestion and 3 percent abnormal vision. In higher doses, abnormal vision became far more common, affecting 11 percent.

Must be logged in to comment.